High Quality Ticagr...

High Quality Ticagrelor

High Quality Ticagrelor

Min.Order / FOB Price:Get Latest Price

10 Gram

Negotiable

  • Min.Order :10 Gram
  • Purity: 99%
  • Payment Terms : T/T,

Keywords

Ticagrelor Ticagrelor powder cas 274693-27-5

Quick Details

  • Appearance:white powder
  • Application:approved for use in the European Union by the European Commission on December 3, 2010.The drug was approved by the US Food and Drug Administration on July 20, 2011.
  • PackAge:aluminum foil bag
  • ProductionCapacity:100|Kilogram|Month
  • Storage:cool and dry place
  • Transportation:email: wonda-chem@outlook.com

Superiority:

1.high quality:

quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.

2.reasonable price:

we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.

3.low moq:

no worry about the low moq, our moq is 1 gram or even lower.

4.good service.

fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.

5. fast shipping and secure courier.

we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.

 

Details:

Product name:  Ticagrelor
Appearance: white powder

CAS NO.:  274693-27-5

Molecular formula: C23H28F2N6O4S
Molecular weight: 522.568

 

Ticagrelor is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved for use in the European Union by the European Commission on December 3, 2010.The drug was approved by the US Food and Drug Administration on July 20, 2011.
Ticagrelor is an antagonist of the P2Y12 receptor.

 

Ticagrelor is a reversible antagonist of the platelet purinergic P2Y12 receptor, which is the main receptor responsible for ADP-induced platelet aggregation.

 

Ticagrelor, a new platelet aggregation inhibitor successfully developed by AstraZeneca (U.S.), is the world’s first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist.
It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome (ACS.) Rapid onset after oral administration, and can effectively improve symptoms of patients with ACS. Thienopyridines is a reversible P2Y12 inhibitor, so it is particularly applicable towards patients who need to undergo anticoagulant therapy before surgery.

Specification

Item

Specifications

Appearance

White or whitish crystalline powder

Identification

IR

HPLC

Loss on drying

≤0.5%

MP ref.

About 146~153 c degree

Optical rotation

Methanol C=1 -40- -60 0°

Residue on Ignition

≤0.5%

Heavy metal

<20ppm

Related substance

Single impurity: ≤0.5%

Total impurities: ≤1.0%

residual Solvent

Methanol<3000

Ethanol<5000

Acetone<5000

N(CH3CH2)3<300

Assay(HPLC)

≥99.0%

Assay by titration

99~101%

 

 

 

Packing and shipping

 

 

 

 

 

 

 

View All
Visit Store

You Might Also Like

Related Searches

Contact Supplier

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View